FENC Strangle Strategy
FENC (Fennec Pharmaceuticals Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
FENC (Fennec Pharmaceuticals Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $193.5M, a beta of 0.91 versus the broader market, a 52-week range of 5.65-9.92, average daily share volume of 176K, a public-listing history dating back to 2017, approximately 32 full-time employees. These structural characteristics shape how FENC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.91 places FENC roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on FENC?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current FENC snapshot
As of May 15, 2026, spot at $9.64, ATM IV 73.90%, IV rank 11.86%, expected move 21.19%. The strangle on FENC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on FENC specifically: FENC IV at 73.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a FENC strangle, with a market-implied 1-standard-deviation move of approximately 21.19% (roughly $2.04 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FENC expiries trade a higher absolute premium for lower per-day decay. Position sizing on FENC should anchor to the underlying notional of $9.64 per share and to the trader's directional view on FENC stock.
FENC strangle setup
The FENC strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FENC near $9.64, the first option leg uses a $10.12 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FENC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FENC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $10.12 | N/A |
| Buy 1 | Put | $9.16 | N/A |
FENC strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
FENC strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on FENC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on FENC
Strangles on FENC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the FENC chain.
FENC thesis for this strangle
The market-implied 1-standard-deviation range for FENC extends from approximately $7.60 on the downside to $11.68 on the upside. A FENC long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current FENC IV rank near 11.86% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on FENC at 73.90%. As a Healthcare name, FENC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FENC-specific events.
FENC strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FENC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FENC alongside the broader basket even when FENC-specific fundamentals are unchanged. Always rebuild the position from current FENC chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on FENC?
- A strangle on FENC is the strangle strategy applied to FENC (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With FENC stock trading near $9.64, the strikes shown on this page are snapped to the nearest listed FENC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are FENC strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the FENC strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 73.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FENC strangle?
- The breakeven for the FENC strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current FENC market-implied 1-standard-deviation expected move is approximately 21.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on FENC?
- Strangles on FENC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the FENC chain.
- How does current FENC implied volatility affect this strangle?
- FENC ATM IV is at 73.90% with IV rank near 11.86%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.